|Year : 2016 | Volume
| Issue : 4 | Page : 384-390
Sometimes endovascular salvage of failing hemodialysis access is indispensable as you may not get another
Hisham Ahmed, El-Sayed A Abd El-Mabood, Refaat S Salama
Department of General Surgery, Benha University, Benha, Egypt
|Date of Submission||16-Apr-2016|
|Date of Acceptance||11-May-2016|
|Date of Web Publication||28-Nov-2016|
El-Sayed A Abd El-Mabood
Benha University Hospital, Benha, 13516
Source of Support: None, Conflict of Interest: None
Purposes This study aimed at salvaging fistulas using percutaneous transluminal balloon angioplasty (PTA) and evaluated the feasibility and safety of this PTA.
Patients and methods A retrospective study was conducted on 15 patients to evaluate the results of endovascular intervention for the treatment of failing arteriovenous fistula from August 2015 until March 2016; these patients included eight (53.3%) men and seven (46.7%) women; most patients were aged between 40 and 60 years.
Results Immediate success rate was 66.4% in anastomotic stenosis, 75% in juxta-anastomotic stenosis, and 100% in cases of central venous and arterial stenosis. Success rate after 6 months was mostly 50%, which necessitated re-PTA, except in central stenosis cases, which showed a success of 100%. Failed procedure was observed in three cases; two were due to puncture site hematoma and vein or anastomotic site rupture; these were treated with open surgery and ligation of the artery and vein proximal and distal to the anastomosis. Thrombosis was the cause of failure in the third case.
Conclusion From this study we conclude that saving access can save life. Failing arteriovenous fistulas can be salvaged with PTA safely and effectively. Results are obtained with less trauma to the patient, preservation of access sites, and less postprocedural pain and wound edema. Centrally located stenoses are accessible. Re-PTA is needed in half of the patients.
Keywords: endovascular salvage, failing hemodialysis access, outcomes
|How to cite this article:|
Ahmed H, Abd El-Mabood ESA, Salama RS. Sometimes endovascular salvage of failing hemodialysis access is indispensable as you may not get another. Egypt J Surg 2016;35:384-90
|How to cite this URL:|
Ahmed H, Abd El-Mabood ESA, Salama RS. Sometimes endovascular salvage of failing hemodialysis access is indispensable as you may not get another. Egypt J Surg [serial online] 2016 [cited 2020 Jun 4];35:384-90. Available from: http://www.ejs.eg.net/text.asp?2016/35/4/384/194738
| Introduction|| |
Hemodialysis, which is the main modality of renal replacement therapy, depends on the ability to maintain good vascular access capable of sustaining high blood flow rates. The native arteriovenous fistula (AVF) is recommended as the first choice because of its superior patency and lower complication rates over grafts and catheters. Vascular access dysfunction is a major cause of morbidity and hospitalization in the hemodialysis population .
Autogenous AVFs and prosthetic arteriovenous grafts (AVG) are necessary for chronic end-stage renal failure patients on hemodialysis. AVFs are the preferred initial hemodialysis access because of their longer patency compared with AVGs. AVGs, however, remain clinically important in patients in whom AVFs are not feasible, and possibly in special populations such as the elderly ,.
In the past when confronted with such failing fistulas, the usual response was to forget this access completely, insert a temporary catheter, and plan for a new access. However, on the basis of the limited number of access sites available for each patient and the increasing life expectancy of patients on regular hemodialysis, the DOQI guidelines recommend early detection and treatment of all hemodynamically significant fistula stenoses, both to extend the life span of each access as long as possible and to avoid the need to use a temporary hemodialysis catheter ,.
Hemodialysis accesses are prone to failure due to thrombosis, usually concomitant with stenosis over the anastomosis or outflow vein. Access thrombosis frequently requires semiemergent salvage intervention, but outcomes are generally unfavorable. Patients may eventually require multiple salvage procedures to restore functionality or for creation of a new access. Some patients require placement of central venous catheters in the interim while the hemodialysis access becomes fully functional. Alternatively, to prevent access failure, clinicians can monitor the performance of these accesses and prophylactically provide interventions to rectify the hemodynamic problems and prolong their patency ,,.
Hemodialysis vascular access dysfunction (which mounts to failure) is classified into early and late failures. At a clinical level, early failure has been defined as an AVF that never develops adequately for dialysis (failure to mature), or which fails within 3 months of starting dialysis. Late failure is defined as failure that occurs more than 3 months from fistula construction or use .
A variety of endovascular interventions have been used, including a combination of venous angioplasty, arterial angioplasty, and accessory vein obliteration. Successful fistula maturation can be achieved in up to 92% of patients. Treatment of discrete stenotic lesions with percutaneous angioplasty is the most readily apparent intervention that would be expected to enhance fistula flow and contribute to successful maturation .
This study aimed to review the effectiveness of endovascular intervention for preservation of failing accesses.
| Patients and methods|| |
The current study was conducted at the General Surgery Department, Benha University, from August 2015 until March 2016. Follow-up data over 6 months were collected from the hospital archives. This retrospective study was conducted on 15 patients to evaluate the results of endovascular intervention for the treatment of failing AVF. These patients had been operated upon from March 2014 until February 2015 and included eight (53.3%) men and seven (46.7%) women; most patients were aged between 40 and 60 years.
The patients included in this study had been operated upon for AVF and had been followed up weekly for 1 month for early detection of failing AVF. A failing AVF was characterized by one or more of the following: (a) reduced thrill of vascular access assessed by clinical palpation by a vascular surgeon; (b) documented decreased dialysis flow rate defined by KDOQI guidelines (access flow less than 600 ml/min, or less than 1000 ml/min with more than 25% decrease over a 4-month period); (c) stenosis detected by duplex ultrasound; (d) nonmaturation of an AVF 6 weeks after creation .
Patients suffering from thrombosed AVF (primary failure), patients with infected fistula, those with a huge aneurysmal dilatation with impending rupture (skin changes), those who developed hypotension when they started dialysis (low cardiac output state), and those who showed sensitivity to the dye used in angioplasty were excluded from the study. Patients lost to follow-up (not coming or died), those with contrast allergy, and those who refused to participate were also excluded.
All patients were submitted to detailed history taking, including history of present illness, detailed cardiac and chest problems, history of previous vascular operations, risk factors, allergy, and history of medical disease, examinations that included palpable and/or audible thrill, the length of the dilated segment, the presence of a competing vein, blood pressure, chest and heart examinations, investigations that included routine laboratory investigations (complete blood count, coagulation profile, ECG, serum creatinine, and blood sugar), duplex that measured the lesions (if present) to determine the size of the balloon and/or stent to be used in each lesion, and finally computed tomography venography to assess central vein stenosis.
The procedure was carried out in the operating room or angiosuite. Patients were prepared for surgical intervention to manage any possible complications. The field was sterilized and the patients were monitored clinically by pulse oximetry in the contralateral limb. The procedure was performed under local anesthesia of the puncture site (2% lidocaine hydrochloride) and light sedation during balloon inflation. All patients were approached percutaneously with an appropriately sized sheath (either radial sheath or standard sheath; usually 6 Fr), which was advanced over a guidewire into either the venous or arterial limb of the fistula. The affected site was evaluated before and after treatment. Fistulograms were offered to all patients with one or more of the above-mentioned features of vascular access failure. The degree of stenosis in the perianastomotic region, fistula, and outflow vein and central veins were assessed during fistulography. Endovascular intervention in the form of balloon angioplasty was performed in the same setting if a stenosis of 50% or more of the vessel diameter is detected on angiography using a standard guidewire. Usually, a 260 cm 0.035″ angled hydrophilic guidewire is inserted in the sheath over a 5- or 4-Fr selective Bern or vertebral catheter under angiographic guidance, which is passed upward into the vein across the lesion supported by the catheter until secured in the central vein. The catheter is advanced passing the lesion; then the wire is removed and the central vein imaged for any stenosis or occlusion. The wire is then readvanced through the catheter until the central vein and exchanged for the balloon. Angioplasty balloon, generally 4×60, is inserted in the perianastomotic region and a 12×40 is inserted for central veins. The balloon is inflated with only enough pressure to obtain full dilatation. A completion fistulogram is performed immediately after angioplasty to determine the success of the procedure. In cases with failed balloon angioplasty a venous stent (wall stent) of compatible size is inserted. All patients were observed in the day surgery ward for 2–3 h and discharged if no acute complications (bleeding or thrombosis) were detected. AVFs, which were functional for dialysis before intervention, were used for dialysis the day after angioplasty .
Postintervention outcomes included immediate success rate (identified by clinical success: ability to carry out three successful hemodialysis sessions using a pump at 300 ml/min or more through the treated fistula; angiographic success: defined as restoration of luminal diameter with less than a 30% residual diameter stenosis; and technical success: restoration of a good propagating thrill), success rate after 6 months, and complications including hematoma, thrombosis, infection, and rupture of the AVF wall during the first 3 h and follow-up for the first 3 months.
The means of all continuous variables were compared by appropriate parametric or nonparametric tests. Categorical variables and proportions were compared using the χ2-test or the Fisher exact test. Results are expressed as medians, percentages, and means±SD.
| Results|| |
During the study period, follow-up data over 6 months were collected from hospital archives; 15 patients with hemodialysis access [eight (53.3%) men and seven (46.7%) women] had failing access confirmed by a fistulogram and subsequently underwent balloon angioplasty for regaining access; most patients were aged between 40 and 60 years. The site of failing AVF was brachiocephalic [nine (60%)] and brachiobasilic [six (40%)]. The associated morbidity was diabetes in 10 cases (66.7%), hypertension in nine cases (60%), and smoking in three cases (20%) ([Table 1] and [Figure 1]).
Failing access was characterized by decreased access dialysis flow rate in seven patients (46.6%) or stenosis detected by duplex ultrasound in four cases (26.7%); other cases were suspected to be due to reduced thrill of vascular access in two cases (13.3%), lack of fistula maturation in one case (6.7%), and difficulty in access for cannulation in one case (6.7%) ([Table 2] and [Figure 2]).
The median time from access creation to the time of first intervention was 10 months (range=2–18 months) for brachiocephalic AVFs but 13 months (range=3–23 months) for brachiobasilic AVFs, as brachiobasilic AVFs sometimes had delayed maturation ([Table 3]).
The majority of stenoses were anastomotic [six (40%)]; all six (100%) underwent successful balloon dilatation and there was no need for stenting; in cases with juxta-anastomotic stenosis [four (26.7%)] successful balloon dilatation was achieved in three (75%) cases and one case (25%) needed stenting; all patients with central venous stenosis [three (20%)] needed stenting (100%) because of failed balloon dilatation but there was no need for stenting in patients with arterial stenosis [two (13.3%)] ([Table 4] and [Figure 3]).
The immediate success rate was 66.4% in anastomotic stenosis (4/6 cases); one of the two failed cases was due to hematoma and the other due to rupture. The success rate was 75% in juxta-anastomotic stenosis (3/4 cases); the failed case was due to complete thrombosis. Immediate success rate was 100% in cases of central venous and arterial stenosis. The success rate after 6 months was 50% in all cases except in central stenosis, in which success was 100% ([Table 5] and [Figure 4]).
In the current study puncture site hematoma were observed in four cases; three of them were small and were treated conservatively but the other one case was treated with open surgery and ligation of the artery and vein proximal and distal to the anastomosis. Vein or anastomotic site rupture occurred in one case and was treated by ligation of the access, whereas infection was observed in two cases, which were treated conservatively with massive antibiotics. Thrombosis was observed in two accesses; one of them was lost and the other was treated conservatively for 2 weeks and saved ([Table 6] and [Figure 5]).
| Discussion|| |
Vascular access for hemodialysis (AVF, AVG, or catheters) should be easy to access, safe, effective, and durable. However, there is no vascular access that satisfies all these requirements all the time and such cases usually require multiple procedures and or interventions. This is because the arteriovenous access is exposed to many factors that could contribute to its failure, which may be early (within the first 3 months) or late (after 3 months). These factors may be arterial (inflow) or venous (outflow) and may be either pre-existing in the patient or related to intraoperative technical errors or postoperative complications .
Stenosis is a common problem for AVFs and AVGs and represents the main cause of dysfunction and thrombosis. The choice of the best method for repair depends on the location of the lesion. Access stenosis has been classified on the basis of its location: juxta-anastomotic (type I), in the cannulable segment (type II), and at the outflow into the deep venous system (type III). There are two additional categories of stenoses not involving the access itself: those of the central veins caused by longstanding catheters and those of the arterial inflow .
All accesses should be evaluated immediately after their creation and routinely examined during their life span. After creation of an AVF or AVG, there should be a palpable thrill or a bruit; the presence of a strong pulse in the draining vein without a thrill or bruit indicates a proximal venous stenosis. Monitoring AVF by physical examination by trained physicians represents an accurate method for diagnosis of malfunction .
Patency of AVFs can be maintained with both open and endovascular revisions . Many investigators feel that the durability of percutaneous transluminal balloon angioplasty (PTA) is too short despite the fact that results of traditional open surgical patch plasty are scarcely reported . Most papers suggest fewer reinterventions after open surgery but there are no randomized prospective studies comparing open versus endovascular surgery in stenoses of native AVFs or prosthetic grafts . According to the National Kidney Foundation (NKF) clinical practice guidelines  the choice of open versus endovascular repair should take into account the local expertise of a center. A primary patency of 50% at 6 months seems to be a reasonable goal for endovascular revision.
Endovascular treatment is tempting as it is a rapid procedure with no surgical wound and shorter hospitalization. Furthermore, the fistula can be used for dialysis immediately after PTA, whereas a temporary central dialysis catheter is often required after open repair. For these reasons, PTA is considered a better treatment for failing fistulas .
In the USA, endovascular intervention has now replaced surgical therapy as the standard management of vascular access dysfunction because of ease, efficiency, and minimal invasiveness, and data from 2009 show that angioplasties to treat AVF dysfunction have increased three-fold from 1998 to 2007 .
Although the transradial approach was the one used and preferred in the current study, other accesses (transvenous, transbrachial, combined, and transulnar) were also used. The transradial access is effective in visualizing and treating both arterial and venous limbs through a retrograde brachial angiogram via one access and permits the operator to stand further away from the image intensifier, thereby reducing radiation exposure. It can also be used diagnostically to map out venous anatomy for surgical revision of an AVF .
In the current study use of stents in central lesions was the treatment of choice to improve long-term patency but balloon angioplasty gave accepted results in other peripheral arterial or venous lesions except in one case (25%) of juxta-anastomotic stenosis, which required a wall stent.
The successful salvage rate in the present study was about 83%, which is greater than that of Miquelin et al. , who showed a salvage rate of 55%. Bhat et al.  showed a slightly higher salvage rate of 88%. A close but slightly lower rate was reported by Falk (74%).
Finally, it is important to set strategy to increase the longevity of AVFs as this dialysis access might be the last resort for dialysis. This strategy must incorporate the efforts of the nephrologists, the dialysis nurse, the vascular surgeon, and the interventionalist. At a minimum, this strategy should be directed toward ensuring that every fistula that is newly created has an opportunity to mature and become a functional access and ensure that every functioning fistula has the best opportunity for longevity.
| Conclusion|| |
Saving access saves life. Failing AVFs can be salvaged with PTA as it is a safe and effective treatment method. Results are obtained with less trauma to the patient. It preserves access sites, causes less postprocedural pain and wound edema, and centrally located stenoses are accessible. Re-PTA is needed in half of the patients.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Clark TW, Cohen RA, Kwak A, Markmann JF, Stavropoulos SW, Patel AA et al.
Salvage of nonmaturing native fistulas by using angioplasty. Radiology 2007; 242:286–292.
Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 2006; 17:807–813.
Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther 2012; 19:263–272.
Gilmore J. KDOQI clinical practice guidelines and clinical practice recommendations − 2006 updates. Nephrol Nurs J 2006; 33:487–488.
Chan MR, Sanchez RJ, Young HN, Yevzlin AS. Vascular access outcomes in the elderly hemodialysis population: a USRDS study. Semin Dial 2007; 20:606–610.
Richardson AI II, Leake A, Schmieder GC, Biuckians A, Stokes GK, Panneton JM, Glickman MH. Should fistulas really be first in the elderly patient? J Vasc Access 2009; 10:199–202.
Bazan HA. Why ‘fistula first’ matters: increased durability, less interventions, and decreased costs. Catheter Cardiovasc Interv 2010; 75:22.
Turmel-Rodrigues L, Mouton A, Birmelé B, Billaux L, Ammar N, Grézard O et al.
Salvage of immature forearm fistulas for haemodialysis by interventional radiology. Nephrol Dial Transplant 2001; 16:2365–2371.
Rundback J, Herman K. TRA for hemodialysis access interventions, Endovascular Today, May 2011.
Miller GA, Goel N, Khariton A, Friedman A, Savransky Y, Trusov I et al.
Aggressive approach to salvage non-maturing arteriovenous fistulae: a retrospective study with follow-up. J Vasc Access 2009; 10:183–191.
Foundation NK. KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 2006; 48(Suppl 1): S1–S322.
Asif A, Gadalean FN, Merrill D, Cherla G, Cipleu CD, Epstein DL, Roth D. Inflow stenosis in arteriovenous fistulas and grafts: a multicenter, prospective study. Kidney Int 2005; 67:1986–1992.
El-Damanawi R, Kershaw S, Campbell G, Hiemstra TF. Successful restoration of arteriovenous dialysis access patency after late intervention, Clin Kidney J 2015; 8:82–86.
Pirozzi N, Garcia-Medina J, Hanoy M. Stenosis complicating vascular access for hemodialysis: indications for treatment. J Vasc Access 2014; 15:76–82.
Coentrão L, Faria B, Pestana M. Physical examination of dysfunctional arteriovenous fistulae by non-interventionalists: a skill worth teaching. Nephrol Dial Transplant 2012; 27:1993–1996.
Tessitore N, Mansueto G, Lipari G, Bedogna V, Tardivo S, Baggio E et al.
Endovascular versus surgical preemptive repair of forearm arteriovenous fistula juxta-anastomotic stenosis: analysis of data collected prospectively from 1999 to 2004. Clin J Am Soc Nephrol 2006; 1:448–454.
Napoli R, Prudenzano F, Russo A, Antonaci M, Aprile N, Buongiorno E. Juxta-anastomotic stenosis of native arteriovenous fistulas: surgical treatment versus percutaneous transluminal angioplasty J Vasc Access 2010; 11:346–351.
Campos M, Nascimento D, Chula D, Nascimento D, Riella M. Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int 2006; 10:152–161.
NKF-DOQI Clinical Practice Guidelines for Vascular Access. Dialysis outcomes quality initiative. Am J Kidney Dis 1997; 30(Suppl 3):150–191.
U.S. Renal Data System. USRDS 2009. Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, Maryland: National Institutes of Health, National Institute of Diabetes and Digestive and kidney Diseases; 2009.
Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ et al.
Severe venous neointimal hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant 2011; 26:2264–2270.
Miquelin DG, Reis LF, Menezes da Silva AA, Pereira de Godoy JM. Percutenous transluminal angioplasty in the treatment of stenosis of arteriovenous fistula for hemodialysis. Int Arch Med 2008; 1:16–19.
Bhat R, McBride K, Chakraverty S, Vikram R, Severn A. Primary cutting balloon angioplasty for treatment of venous stenoses in native hemodialysis fistulas: long-term results from three centers. Cardiovasc Intervent Radiol 2007; 30 1166-1170; discussion 1171-1172.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]